理气消胀口服液治疗脾虚气滞证功能性消化不良的临床疗效评价

Clinical evaluation of Liqixiaozhang oral liquid in treating functional dyspepsia of spleen deficiency syndrome

目的观察理气消胀口服液治疗脾虚气滞证功能性消化不良的临床疗效评价。方法选取2017-05~2017-10延安市中医医院内科门诊脾虚气滞证功能性消化不良病例72例,随机分为治疗组与对照组各36例,治疗组给予理气消胀口服液,对照组给予多潘立酮片,对两组患者的单项症状积分、症状疗效、证候积分、证候疗效进行统计学分析。结果治疗组患者症状积分均显著低于正常对照组(P<0.05),总有效率97.2%(35/36),显著高于正常对照组80.6%(29/36)(P<0.05),证候总积分均显著低于正常对照组(P<0.05),总有效率83.3%(30/36),显著高于正常对照组63.9%(23/36)(P<0.05),PRO评分、SF-36评分均显著高于正常对照组(P<0.05)。结论理气消胀口服液治疗脾虚气滞证功能性消化不良的疗效显著。

Objective To observe the clinical efficacy evaluation of the treatment of the functional dyspepsia of spleen deficiency syndrome by the treatment of Liqixiaozhang oral liquid. Methods A total of 72 cases of dyspepsia with spleen deficiency syndrome were selected from Internal Medicine Clinics of Yan＇an Hospital of Traditional Chinese Medicine from May 2017 to October2017. The patients were randomly divided into treatment group（ 36 cases） and control group（ 36 cases）. The treatment group was treated with Liqixiaozhang oral liquid,and the control group was given domperidone tablets. Statistical analysis was made on the symptom scores,symptom scores,symptom scores and syndromes of the two groups. Results The symptom score of the treatment group was significantly lower than that of the normal control group（ P〈0. 05）. The total effective rate was 97. 2% （ 35/36）,significantly higher than that of the normal control group（ 80. 6% ,29/36）（ P〈0. 05）. The total score was significantly lower than that of the normal control group（ P〈0. 05）. The total effective rate was 83. 3% （ 30/36） significantly higher than 63. 9% （ 23/36） of the normal control group（ P〈0. 05） The score was significantly higher than the normal control group（ P〈0. 05）. Conclusion The therapeutic effect of Liqixiaozhang oral liquid on functional dyspepsia with spleen deficiency syndrome is obvious.